ClinicalTrials.gg
RecruitingNCT07445035Updated Jul 1, 2026

Effects of Mobilization Using a Powered Lower-limb Exoskeleton With Prolonged Mechanical Ventilation

An interventional study of lower-limb exoskeleton and Standard medical treatment in Prolonged Mechanical Ventilation, Ventilator Weaning and Ventilator Dependent, sponsored by Fu Jen Catholic University. Recruiting at 1 site in Taiwan. Open to participants aged 45 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-07-01.

Sponsored by Fu Jen Catholic University · Not applicable, Interventional, and Other

How we know

From the registry’s dates

  • Started Jun 2026; still recruiting 4 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Non-randomized
Ages
45 Years to 65 Years
Sex
All
01

Study summary

This study aims to evaluate the effects of powered lower-limb exoskeleton-assisted training on lower limb strength, respiratory parameters, 28-day ventilator-free days, and length of hospital stay in patients with prolonged mechanical ventilation admitted to a Respiratory Care Center. The goal is to provide clinical evidence for integrating rehabilitation and respiratory care in this patient population.

Read the detailed description

Background:

Patients with prolonged mechanical ventilation often experience lower limb muscle weakness, respiratory muscle dysfunction, and impaired functional status due to prolonged bed rest, leading to lower weaning success rates and extended hospital stays. In recent years, exoskeleton robots have emerged as assistive training tools and have demonstrated potential in improving lower limb function and cardiopulmonary endurance in neurological and orthopedic populations. However, evidence supporting their use in prolonged mechanical ventilation patients remains limited.

Study Design: This study will be conducted in the Respiratory Care Center of Fu Jen Catholic University Hospital using purposive sampling.

Methods:

A total of 30 prolonged mechanical ventilation patients will be recruited and matched in a 1:1 ratio based on gender, age, and intensive care unit length of stay. The intervention group will receive exoskeleton-assisted training, while the control group will receive standard care without the intervention. Recruitment and informed consent will be conducted by research staff unaffiliated with the Respiratory Care Center.

Effect:

The study is expected to identify differences between the exoskeleton intervention and control groups in terms of lower limb muscle strength, respiratory physiological parameters, 28-day ventilator-free days, and hospital length of stay. The results will provide scientific evidence and practical guidance for the clinical integration of exercise rehabilitation and respiratory care for prolonged mechanical ventilation patients.

Key words:

Prolonged Mechanical Ventilation, Exoskeleton Robot, Exercise Training, Lower Limb Muscle Strengthening, Ventilator Weaning

02

Conditions studied

  • Prolonged Mechanical Ventilation
  • Ventilator Weaning
  • Ventilator Dependent
  • Exoskeleton Device
  • Exercise Training

Keywords

  • prolonged mechanical ventilation
  • ventilator weaning
  • lower limb muscle strengthening
  • exoskeleton robot
  • exercise training
03

In context

Lead sponsor

Fu Jen Catholic University is the lead sponsor of 48 studies on the registry; 22 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
45 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Able to maintain a seated position for at least 1 minute.
  • The participant or their legal representative is able to sign the form.

Exclusion criteria

Exclusion Criteria:

  • Inability to follow instructions.
  • Intubation/tracheostomy prior to current admission.
  • Diagnosis of severe left heart failure.
  • Diagnosis of neuromuscular disorders.
  • Unable to stand.
  • Complete paralysis of the lower extremities.
  • Presence of unhealed ulcers in the lower extremities.
  • Deep vein thrombosis of the lower extremities.
  • Lower-limb amputation.
  • Severe hypertension
  • Severe cardiac conditions
  • Severe bilateral joint disorders
  • Severe pain while standing
  • Severe osteoporosis
  • Lower-limb fracture
  • Ongoing epileptic seizure
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Active comparator
    standard care group

    receive standard care without the intervention

    Other: Standard medical treatment

  • Experimental
    Powered lower-limb exoskeleton group

    receive standard care with exoskeleton-assisted training

    Device: lower-limb exoskeleton

Interventions

  • Devicelower-limb exoskeleton

    regular therapy plus exoskeleton training

  • OtherStandard medical treatment

    regular therapy

06

What researchers measure

Primary outcomes

  1. manual muscle testing

    0 indicates no detectable muscle contraction, and 5 represents normal muscle strength.

    Time frame: 2 weeks

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jun 2026 (actual). Primary completion is estimated for Dec 2026, 6 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 25, 2026
First posted
Mar 3, 2026
StartActual
Jun 26, 2026
Primary completionEst.
Dec 31, 2026
CompletionEst.
Dec 31, 2026
Last update
Jul 1, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 1, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07445035
Lead sponsor
Fu Jen Catholic University
Responsible party
Ke-Yun, Chao (Assistant Professor, Fu Jen Catholic University) — Principal investigator
First posted
Mar 3, 2026
Start date
Jun 26, 2026
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Jul 1, 2026

Study contacts

Ke-Yun Chao, PhD
Contact
C00152@mail.fjuh.fju.edu.tw
+886-905-301-879
Ke-Yun Chao, PhD
principal investigator · Fu Jen Catholic University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion